Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Pharmacoelectroencephalographic profile of befloxatone, a new reversible MAO-A inhibitor, in healthy subjects. [electronic resource] by
- Luthringer, R
- Dago, K T
- Patat, A
- Caille, P
- Curet, O
- Durieu, G
- Rinaudo, G
- Toussaint, M
- Granier, L A
- Macher, J P
Producer: 19970212
In:
Neuropsychobiology vol. 34
Availability: No items available.
|
|
17.
|
Phase II trial of elliptinium in advanced renal cell carcinoma. [electronic resource] by
- Caillé, P
- Mondesir, J M
- Droz, J P
- Kerbrat, P
- Goodman, A
- Ducret, J P
- Theodore, C
- Spielman, M
- Rouëssé, J
- Amiel, J L
Producer: 19850919
In:
Cancer treatment reports vol. 69
Availability: No items available.
|
|
18.
|
Drug-induced antibodies during 2-N-methyl-9-hydroxyellipticinium acetate (NSC-264137) treatment: schedule dependency and relationship to hemolysis. [electronic resource] by
- Mondesir, J M
- Bidart, J M
- Goodman, A
- Alberici, G F
- Caille, P
- Troalen, F
- Rouesse, J
- Bohuon, C
- Gralla, R J
- Einzig, A I
Producer: 19850628
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 3
Availability: No items available.
|
|
19.
|
|
|
20.
|
[Treatment of metastatic renal cancer in adults with elliptinium acetate]. [electronic resource] by
- Amiel, J L
- Rouessé, J
- Droz, J P
- Caille, P
- Travagli, J P
- Théodore, C
- Le Chevalier, T
- Ducret, J P
- Bidart, M
- Garnier, H S
Producer: 19840820
In:
Presse medicale (Paris, France : 1983) vol. 13
Availability: No items available.
|